 | • レポートコード：QYR9N7169 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、鼻出血薬のグローバル市場について調査・分析したレポートで、種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他）、用途別（病院、診療所、小売薬局、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・鼻出血薬の世界市場規模 ・主要企業別市場シェア ・鼻出血薬の世界市場規模：種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他） ・鼻出血薬の世界市場規模：用途別（病院、診療所、小売薬局、その他） ・鼻出血薬のアメリカ市場規模（種類別、用途別） ・鼻出血薬のヨーロッパ市場規模（種類別、用途別） ・鼻出血薬の中国市場規模（種類別、用途別） ・鼻出血薬の日本市場規模（種類別、用途別） ・鼻出血薬の東南アジア市場規模（種類別、用途別） ・鼻出血薬のインド市場規模（種類別、用途別） ・鼻出血薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・鼻出血薬の世界市場予測（2019年-2025年） ・鼻出血薬の地域別市場予測（2019年-2025年） ... |
A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils.Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining.
In 2018, the global Epistaxis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Epistaxis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epistaxis Drugs development in United States, Europe and China.
The key players covered in this study
Pfizer
GlaxoSmithKline
Smith & Nephew
Bristol-Myers Squibb
Medline Industries
Ciron Drugs & Pharmaceuticals
…
Market segment by Type, the product can be split into
Vasoconstrictors
Anesthetics
Antibiotic Ointments
Cauterizing Agents
Others
Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Epistaxis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Epistaxis Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Epistaxis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Epistaxis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Vasoconstrictors
1.4.3 Anesthetics
1.4.4 Antibiotic Ointments
1.4.5 Cauterizing Agents
1.4.6 Others
1.5 Market by Application
1.5.1 Global Epistaxis Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Epistaxis Drugs Market Size
2.2 Epistaxis Drugs Growth Trends by Regions
2.2.1 Epistaxis Drugs Market Size by Regions (2014-2025)
2.2.2 Epistaxis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Epistaxis Drugs Market Size by Manufacturers
3.1.1 Global Epistaxis Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Epistaxis Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Epistaxis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Epistaxis Drugs Key Players Head office and Area Served
3.3 Key Players Epistaxis Drugs Product/Solution/Service
3.4 Date of Enter into Epistaxis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Epistaxis Drugs Market Size by Type (2014-2019)
4.2 Global Epistaxis Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Epistaxis Drugs Market Size (2014-2019)
5.2 Epistaxis Drugs Key Players in United States
5.3 United States Epistaxis Drugs Market Size by Type
5.4 United States Epistaxis Drugs Market Size by Application
6 Europe
6.1 Europe Epistaxis Drugs Market Size (2014-2019)
6.2 Epistaxis Drugs Key Players in Europe
6.3 Europe Epistaxis Drugs Market Size by Type
6.4 Europe Epistaxis Drugs Market Size by Application
7 China
7.1 China Epistaxis Drugs Market Size (2014-2019)
7.2 Epistaxis Drugs Key Players in China
7.3 China Epistaxis Drugs Market Size by Type
7.4 China Epistaxis Drugs Market Size by Application
8 Japan
8.1 Japan Epistaxis Drugs Market Size (2014-2019)
8.2 Epistaxis Drugs Key Players in Japan
8.3 Japan Epistaxis Drugs Market Size by Type
8.4 Japan Epistaxis Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Epistaxis Drugs Market Size (2014-2019)
9.2 Epistaxis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Epistaxis Drugs Market Size by Type
9.4 Southeast Asia Epistaxis Drugs Market Size by Application
10 India
10.1 India Epistaxis Drugs Market Size (2014-2019)
10.2 Epistaxis Drugs Key Players in India
10.3 India Epistaxis Drugs Market Size by Type
10.4 India Epistaxis Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Epistaxis Drugs Market Size (2014-2019)
11.2 Epistaxis Drugs Key Players in Central & South America
11.3 Central & South America Epistaxis Drugs Market Size by Type
11.4 Central & South America Epistaxis Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Epistaxis Drugs Introduction
12.1.4 Pfizer Revenue in Epistaxis Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Epistaxis Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Epistaxis Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Smith & Nephew
12.3.1 Smith & Nephew Company Details
12.3.2 Company Description and Business Overview
12.3.3 Epistaxis Drugs Introduction
12.3.4 Smith & Nephew Revenue in Epistaxis Drugs Business (2014-2019)
12.3.5 Smith & Nephew Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Epistaxis Drugs Introduction
12.4.4 Bristol-Myers Squibb Revenue in Epistaxis Drugs Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Medline Industries
12.5.1 Medline Industries Company Details
12.5.2 Company Description and Business Overview
12.5.3 Epistaxis Drugs Introduction
12.5.4 Medline Industries Revenue in Epistaxis Drugs Business (2014-2019)
12.5.5 Medline Industries Recent Development
12.6 Ciron Drugs & Pharmaceuticals
12.6.1 Ciron Drugs & Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Epistaxis Drugs Introduction
12.6.4 Ciron Drugs & Pharmaceuticals Revenue in Epistaxis Drugs Business (2014-2019)
12.6.5 Ciron Drugs & Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Epistaxis Drugs Key Market Segments
Table Key Players Epistaxis Drugs Covered
Table Global Epistaxis Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Epistaxis Drugs Market Size Market Share by Type 2014-2025
Figure Vasoconstrictors Figures
Table Key Players of Vasoconstrictors
Figure Anesthetics Figures
Table Key Players of Anesthetics
Figure Antibiotic Ointments Figures
Table Key Players of Antibiotic Ointments
Figure Cauterizing Agents Figures
Table Key Players of Cauterizing Agents
Figure Others Figures
Table Key Players of Others
Table Global Epistaxis Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Retail Pharmacies Case Studies
Figure Others Case Studies
Figure Epistaxis Drugs Report Years Considered
Table Global Epistaxis Drugs Market Size 2014-2025 (Million US$)
Figure Global Epistaxis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Epistaxis Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Epistaxis Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Epistaxis Drugs Market Share by Regions 2014-2019
Figure Global Epistaxis Drugs Market Share by Regions 2014-2019
Figure Global Epistaxis Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Epistaxis Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Epistaxis Drugs Market Share by Manufacturers (2014-2019)
Figure Global Epistaxis Drugs Market Share by Manufacturers in 2018
Table Global Epistaxis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Epistaxis Drugs Product/Solution/Service
Table Date of Enter into Epistaxis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Epistaxis Drugs Market Size Share by Type (2014-2019)
Figure Global Epistaxis Drugs Market Size Market Share by Type (2014-2019)
Table Global Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Epistaxis Drugs Market Size Share by Application (2014-2019)
Figure Global Epistaxis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Epistaxis Drugs Revenue Market Share by Application in 2018
Figure United States Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Epistaxis Drugs Market Share (2018-2019)
Table United States Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Epistaxis Drugs Market Share by Type (2014-2019)
Table United States Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Epistaxis Drugs Market Share by Application (2014-2019)
Figure Europe Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Epistaxis Drugs Market Share (2018-2019)
Table Europe Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Epistaxis Drugs Market Share by Type (2014-2019)
Table Europe Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Epistaxis Drugs Market Share by Application (2014-2019)
Figure China Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Epistaxis Drugs Market Share (2018-2019)
Table China Epistaxis Drugs Market Size by Type (2014-20189) (Million US$)
Table China Epistaxis Drugs Market Share by Type (2014-2019)
Table China Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table China Epistaxis Drugs Market Share by Application (2014-2019)
Figure Japan Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Epistaxis Drugs Market Share (2018-2019)
Table Japan Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Epistaxis Drugs Market Share by Type (2014-2019)
Table Japan Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Epistaxis Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Epistaxis Drugs Market Share (2018-2019)
Table Southeast Asia Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Epistaxis Drugs Market Share by Type (2014-2019)
Table Southeast Asia Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Epistaxis Drugs Market Share by Application (2014-2019)
Figure India Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Epistaxis Drugs Market Share (2018-2019)
Table India Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table India Epistaxis Drugs Market Share by Type (2014-2019)
Table India Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table India Epistaxis Drugs Market Share by Application (2014-2019)
Figure Central & South America Epistaxis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Epistaxis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Epistaxis Drugs Market Share (2018-2019)
Table Central & South America Epistaxis Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Epistaxis Drugs Market Share by Type (2014-2019)
Table Central & South America Epistaxis Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Epistaxis Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Epistaxis Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Epistaxis Drugs Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Epistaxis Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Epistaxis Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Smith & Nephew Company Details
Table Smith & Nephew Revenue in Epistaxis Drugs Business (2014-2019)(Million US$)
Figure Smith & Nephew Revenue Growth Rate in Epistaxis Drugs Business (2014-2019)
Table Smith & Nephew Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Epistaxis Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Epistaxis Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Medline Industries Company Details
Table Medline Industries Revenue in Epistaxis Drugs Business (2014-2019)(Million US$)
Figure Medline Industries Revenue Growth Rate in Epistaxis Drugs Business (2014-2019)
Table Medline Industries Recent Development
Table Ciron Drugs & Pharmaceuticals Company Details
Table Ciron Drugs & Pharmaceuticals Revenue in Epistaxis Drugs Business (2014-2019)(Million US$)
Figure Ciron Drugs & Pharmaceuticals Revenue Growth Rate in Epistaxis Drugs Business (2014-2019)
Table Ciron Drugs & Pharmaceuticals Recent Development
Table Global Epistaxis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Epistaxis Drugs Market Size Share by Regions (2019-2025)
Figure Global Epistaxis Drugs Market Size Share by Regions in 2025
Figure United States Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Epistaxis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Epistaxis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Epistaxis Drugs Market Size by Product (2019-2025)
Figure Global Epistaxis Drugs Market Size by Product in 2025
Table Global Epistaxis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Epistaxis Drugs Market Size by Application (2019-2025)
Figure Global Epistaxis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のグラム陽性菌感染症治療薬市場：市場規模・現状・予測 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.In 2018, the global Gram-positive Bacterial Infection Drugs market size was xx million US$ and it is expected to reach xx million US$ by …- 世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …
- 世界の神経因性疼痛治療薬市場：市場規模・現状・予測 Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).In terms of value, North America is a large market and is expected to …
- 世界の一般的な腫瘍治療薬市場：市場規模・現状・予測 In 2018, the global Generic Oncology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key playe…
- 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測 Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximate…